Advertisement
Screener

Deciphera Pharmaceuticals, Inc. Patents: Applications Pending

Deciphera Pharmaceuticals, Inc. Patent Applications Pending

223 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2026-05-29: Application 19692361; Invention SOLID STATE FORMS OF A KINASE INHIBITOR; Applicant Deciphera Pharmaceuticals, LLC; Status Publications -- Issue Fee Payment Received.
  • 2026-05-29: Application 19692333; Invention SOLID STATE FORMS OF A KINASE INHIBITOR; Applicant Deciphera Pharmaceuticals, LLC; Status Publications -- Issue Fee Payment Received.
  • 2026-05-27: Application 19689564; Invention CSF-1R INHIBITORS AND METHODS OF USE THEREOF; Applicant Deciphera Pharmaceuticals, LLC; Status Special New.
  • 2026-05-27: Application 19689541; Invention CSF-1R INHIBITORS AND METHODS OF USE THEREOF; Applicant Deciphera Pharmaceuticals, LLC; Status Special New.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2026-05-2919692361SOLID STATE FORMS OF A KINASE INHIBITORDeciphera Pharmaceuticals, LLCPublications -- Issue Fee Payment ReceivedUS20260285844A1
Elena Kostik
Michael D. Kaufman
United States
United States
ABDALHAMEED, MANAHIL MIRGHANI ALI
2026-05-2919692333SOLID STATE FORMS OF A KINASE INHIBITORDeciphera Pharmaceuticals, LLCPublications -- Issue Fee Payment ReceivedUS20260285843A1
Elena Kostik
Michael D. Kaufman
United States
United States
ABDALHAMEED, MANAHIL MIRGHANI ALI
2026-05-2719689564CSF-1R INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCSpecial NewUS20260285842A1
Elena Kostik
Ann Gelormini
Michael D. Kaufman
United States
United States
United States
WEDDINGTON, KEVIN E
2026-05-2719689541CSF-1R INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCSpecial NewUS20260285841A1
Elena Kostik
Ann Gelormini
Michael D. Kaufman
United States
United States
United States
WEDDINGTON, KEVIN E
2026-05-2719689517CSF-1R INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCSpecial NewUS20260285840A1
Elena Kostik
Ann Gelormini
Michael D. Kaufman
United States
United States
United States
WEDDINGTON, KEVIN E
2026-04-2819661067METHODS OF TREATING DISORDERS USING CSF1R INHIBITORSDeciphera Pharmaceuticals, LLCSpecial NewUS20260240849A1
Daniel L. Flynn
Bryan D. Smith
Rodrigo Ruiz Soto
Keisuke Kuida
United States
United States
United States
United States
HENLEY III, RAYMOND J
2026-04-0319638815PROCESSES OF MAKING CSF-1R INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCDocketed New Case - Ready for ExaminationUS20260234127A1
Elena Kostik
Ann Gelormini
Michael D. Kaufman
United States
United States
United States
CENTRAL, DOCKET
2026-02-2419548540METHODS OF TREATING DISORDERS USING CSF1R INHIBITORSDeciphera Pharmaceuticals, LLCDocketed New Case - Ready for ExaminationUS20260207601A1
Daniel L. Flynn
Bryan D. Smith
Rodrigo Ruiz Soto
Keisuke Kuida
United States
United States
United States
United States
CENTRAL, DOCKET
2026-02-2019545401FORMULATIONS OF VIMSELTINIBDeciphera Pharmaceuticals, LLCFinal Rejection MailedUS20260174760A1
Ehab Hamed
United States
PAK, JOHN D
2026-02-1919544595FORMULATIONS OF VIMSELTINIBDeciphera Pharmaceuticals, LLCFinal Rejection MailedUS20260183294A1
Ehab Hamed
United States
LEE, SIN J
2026-01-29PCTUS2026012978CDK INHIBITORS AND METHODS OF USE THEREOFDECIPHERA PHARMACEUTICALS, LLCRO PROCESSING COMPLETED-PLACED IN STORAGE
ANDREW M. HARNED
YU MI AHN
DANIEL L. FLYNN
BERTRAND LE BOURDONNEC
HUNTER PICARD
SAQIB FAISAL
United States
United States
United States
United States
United States
United States